78.7%
Chimeric antigen receptor (CAR) T cell therapysolid tumorsDNMTihematological cancerDNMTi-exposedDNMTis
…Background Chimeric antigen receptor (CAR) T cell therapy has revolutionized hematological cancer treatment but faces sig…
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 1,741–1,800 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
booster treatment sessions1botulinum toxin1botulinum toxin treatment1cardioversion1carotid artery revascularization1carotid revascularization1caudal blocks1checkpoint inhibition1chemo-drug-optimisation1chemoimmunotherapy combinations1chemoprevention1chlamydia treatment1chronic dialysis1chronic opioid therapy1cochlear implant1combination therapies1complementary medicine1consolidation therapy1continuous neuraxial analgesia1continuous therapy1conventional mastectomy1corrective braces1curative-intent external beam radiotherapy1curative-intent radiotherapy1curative-intent resection1cures1diabetes treatments1digital therapeutics1direct EVT1distal radial osteotomy1doublet therapies1drug tapering1drug treatment interventions1early paracentesis1empirical therapy1endodontic therapy1endoscopic cystoventriculostomy1endothelial keratoplasty/prosthesis1endovascular radiosurgery1enhanced bowel preparation1extemporaneous compounding1extrauterine placental transfusion1fascial plane block1fertility-sparing treatment1first-line treatment1flow diverter stenting1folate supplementation1frameless navigated aspiration1gastrostomy feeding1glycaemic control1hand-arm bimanual intensive therapy1helmet non-invasive ventilation1high frequency bronchoscopic MWA1hip or knee arthroplasty1home parenteral nutrition1hybrid DCB approach1hydrostatic reduction1hyperbolic tapering1hypnosis1hypoglycemic treatment1
Articles mentioning treatments
7,227 articles · page 495 of 603Autologous CAR-T cell therapieshematologic malignanciesIITautoimmune diseasesAID
…Background Autologous CAR-T cell therapies have demonstrated remarkable efficacy in hematologic malignanci…
BCMA-targeting CAR-T cell therapymultiple myelomaLTG3551cilta-celNew England Journal of Medicineciltacabtagene autoleucelIde-celMMidecabtagene vicleucel
…pokinetic movement disorder with features of parkinsonism after BCMA-targeting CAR-T cell therapy. Nature medicine. 2021 Dec;27(12):2099-103.Gust J. BCMA-CAR T-c…
Chimeric Antigen Receptor T (CAR-T) cell therapysolid tumourshaematological malignanciesEuropean Research CouncilERCanticancer drugsMinisterio de Educacion y Formacion ProfesionalHorizon 2020 research and innovation programmesolid tumorsICoMICS
…Background Chimeric Antigen Receptor T (CAR-T) cell therapy has demonstrated remarkable success in treating haematological …
75.5%
Chimeric Antigen Receptor T (CAR T) cell therapiesAB-3028mCRPCsolid tumorsTCGAhematological malignanciesmetastatic castration-resistant prostate cancer (mCRPC)The Cancer Genome Atlasprostate tumorsGTEx
…Background Chimeric Antigen Receptor T (CAR T) cell therapies have achieved curative outcomes in some hematological malignanc…
chimeric antigen receptor T cell (CAR-T) therapyglioblastoma multiformeGBM
… is a potential strategy for enhancing immunotherapies, such as chimeric antigen receptor T cell (CAR-T) therapy, providing a promising avenue for treating aggressive tumors su…
CAR-T cell therapysolid tumorshematological malignanciesAC484ABBV-CLS-484
…Background Adoptive cellular therapy (ACT) in the form of CAR-T cell therapy has demonstrated potent clinical efficacy in hematological mali…
CAR-T cell therapiesAcute myeloid leukemiaChampions OncologyGM-CSFTaconic BiosciencesAMLIL-3
…ncluding monoclonal antibodies, bispecific T-cell engagers, and CAR-T cell therapies—in a system that preserves both human immune functionality and …
T Cell Receptor (TCR)-Based cellular therapyipilimumabnivolumabFibrolamellar carcinoma (FLC)DNAJ-PKAcJohns Hopkins IRB
…all goal is to target this ‘undruggable’ oncogenic driver using T Cell Receptor (TCR)-Based cellular therapy.Methods We are performing a clinical trial of a peptide-based t…
adoptive cell therapysolid tumorsRoswell Park Comprehensive Cancer Centerovarian cancerRPCCC
…of IVS generating polyclonal cytotoxic T lymphocytes (CTLs) for adoptive cell therapy against highly heterogenous solid tumors remain to be establish…
Trastuzumab-based treatmentsTrastuzumab deruxtecantrastuzumab-deruxtecanHER2-low breast cancerHER2-low tumorstrastuzumabhuman breast cancermetastatic breast cancerU of North Texas
…xpressing tumors, do not depend on HER2 signaling for survival. Trastuzumab-based treatments have failed to improve the outcomes of patients with HER2-low b…
cancer immunotherapy
… across diverse tumor types and represent promising targets for cancer immunotherapy. Clinical trials targeting these neoantigens have shown encoura…